A new mathematical model suggests that the development of a vaccine against HIV, even if it is only partially effective, could be hugely important for the elimination of HIV worldwide.
Researchers looking at the genome of M. tuberculosis have discovered that HIV co-infection could be influencing how the bacteria are evolving.
A new systematic evidence review has discovered that FDA-approved direct-acting antiviral regimens are effective against all genotypes of hepatitis C.
Study demonstrates the value of phage therapy in effectively treating Pseudomonas aeruginosa infections.
A Phase I clinical trial has demonstrated two investigational Ebola vaccines generate a durable immune response 1 year after vaccination.
Researchers have demonstrated that Trypanosoma brucei, the parasite responsible for sleeping sickness, has its own molecular clock, which could affect the parasite’s sensitivity to treatments.
Researchers have demonstrated that MRI scans could help to diagnose patients with cognitive problems due to HIV-related inflammation, presenting an alternative to lumbar punctures.
New findings have identified the exact mechanism by which the bacterium Salmonella typhimurium can escape degradation by autophagy.
Researchers have suggested Zika may have adverse effects on the cardiovascular system based on new data from a small case report; an association which has previously been unreported.
New study in mouse models suggests immune adaptation in pregnancy reduces the antiviral response allowing the influenza virus to mutate to more virulent strains and causing more severe infections.